Joseph C. Presti - Concepedia

Author

Joseph C. Presti

Also Known As

CHRISTOPHER L. AMLING, FREDERICK DOREY, J C Presti, J Presti, J. C. Presti, J. Presti, J.C. Presti, JC Presti, JOSEPH C. JR. PRESTI, JOSEPH C. PRESTI

376

Publications

14K

Citations

H-Index

Concepts

All Affiliations

Stanford University University of California, San Francisco University of California, Los Angeles Augusta University Duke University

About

Joseph C. Presti is an author at Stanford University specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	68	5.8K
2	Health Sciences	9	9	807
3	Public Health	7	7	227
4	Arts	1	1	44
5	Engineering	1	1	182

Joseph C. Presti

162

Publications

13K

Citations

H-Index

Page 1

	Year	Citations
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells Keith Syson Chan, Íñigo Espinosa, Mark P. Chao, Proceedings of the National Academy of Sciences Clinical PrognosisCancer BiologyMolecular HeterogeneityTumor BiologyMolecular Characterization	2009	673
THE OPTIMAL SYSTEMATIC PROSTATE BIOPSY SCHEME SHOULD INCLUDE 8 RATHER THAN 6 BIOPSIES: RESULTS OF A PROSPECTIVE CLINICAL TRIAL Joseph C. Presti, JAMES J. CHANG, Vivek Bhargava, The Journal of Urology	2000	497
Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer Christopher King, James D. Brooks, Harcharan Gill, International Journal of Radiation OncologyBiologyPhysics UrologySurgical OncologyRadiation TherapyMedicineBrachytherapy	2011	402
Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group Stephen J. Freedland, William J. Aronson, Christopher J. Kane, Journal of Clinical Oncology	2003	387
Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer Lionel L. Bañez, Robert J. Hamilton, Alan W. Partin, JAMA	2007	353
Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice Study Joseph C. Presti, Gerard J. O’Dowd, M. Craig Miller, The Journal of Urology	2003	331
Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical Trial Christopher R. King, James D. Brooks, Harcharan Gill, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapySurgical OncologyUrologyRadiation TherapyMedicine	2008	320
A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer H. Barton Grossman, Leonard G. Gomella, Yves Fradet, The Journal of Urology	2007	297
Genetic alterations in bladder cancer Guido Dalbagni, Joseph C. Presti, William R. Fair, The Lancet UrologyGenitourinary CancerCancer GenomicsCancer GeneticsMedicine	1993	239
Molecular genetic alterations in superficial and locally advanced human bladder cancer. Joseph C. Presti, V E Reuter, T. Iscar Galan, PubMed UrologyCancer PathologyHuman Bladder CancerTumor HeterogeneityMedicine	1991	230

Page 1